Generate a tailored SOP for Dr. Danijela Kocic. Improve your application with a focused, well-structured draft.
Danijela Kocic is the Scientific Head of Clinical Pharmacology and Toxicology for SydPath at St. Vincent’s Hospital in Sydney, Australia. She manages the analysis of Therapeutic Drug Monitoring results for clinicians and patients, ensuring rigorous analytical services to optimize patient outcomes in various complex clinical settings. Dr. Kocic is an active member of the TDM Matters Multi-Disciplinary Team Service at St. Vincent’s Hospital and has been appointed as a Conjoint Lecturer at St Vincent’s Clinical School, University of New South Wales. Previously, she worked as a Research Scientist at Novartis Pharmaceuticals and has served as a Senior Scientist in Charge of Research & Development at the Drug Toxicology Unit of the NSW Forensic Analytical Scientific Service. Her research interests include improving sample throughput in standard LC-MS/MS equipment using Active Flow Technology and personalizing medicine through Therapeutic Drug Monitoring.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.